IL SB3213 | 2025-2026 | 104th General Assembly

Status

Sponsorship: Slight Partisan Bill (Democrat 5-3)
Status: Enrolled on May 31 2026 - 75% progression
Action: 2026-05-31 - Passed Both Houses
Text: Latest bill text (Enrolled) [HTML]

Summary

Amends the Pharmacy Practice Act. Provides that prescriptions for drugs in Schedules II, III, IV, and V (rather than Schedules III, IV, and V controlled substances) of the Illinois Controlled Substances Act may be transferred only once and may not be further transferred, consistent with federal regulations concerning the prescription, administering, and dispensing of controlled substances. Provides that upon a patient's request, a pharmacy must transfer the prescription to another pharmacy, including Schedule II controlled substances, if the prescription has been received but not yet filled. Provides that the transfer is not required if: (1) the prescriber prohibits transfer in writing on the prescription and documents a clinical reason prohibiting transfer on the prescription; or (2) the transfer is otherwise prohibited by federal law. Provides that transfers may occur electronically or by facsimile when permitted by federal law, and a licensed pharmacy technician may perform the transfer if delegated by a pharmacist. Amends the Illinois Controlled Substances Act. Provides that a prescriber shall not be required to issue prescriptions electronically: (1) prescriptions issued prior to January 1, 2028 that may need to be filled outside of typical retail pharmacy operating hours; or (2) prescriptions issued prior to January 1, 2028 that may be difficult to obtain because the prescriber knows of drug shortages or pharmacy inventory limitations.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

ELECTRONIC PRESCRIPTIONS

Sponsors


History

DateChamberAction
2026-05-31SenatePassed Both Houses
2026-05-31SenateSenate Concurs
2026-05-31SenateHouse Floor Amendment No. 1 Senate Concurs 056-000-000
2026-05-29SenateHouse Floor Amendment No. 1 Motion To Concur Recommended Do Adopt Licensed Activities; 007-000-000
2026-05-28SenateHouse Floor Amendment No. 1 Motion to Concur Assignments Referred to Licensed Activities
2026-05-28SenateHouse Floor Amendment No. 1 Motion to Concur Referred to Assignments
2026-05-28SenateHouse Floor Amendment No. 1 Motion to Concur Filed with Secretary Sen. Steve McClure
2026-05-28SenatePlaced on Calendar Order of Concurrence House Amendment(s) 1 - May 29, 2026
2026-05-28SenateSecretary's Desk - Concurrence House Amendment(s) 1
2026-05-27HouseAdded Alternate Co-Sponsor Rep. Michelle Mussman
2026-05-27HouseAdded Alternate Co-Sponsor Rep. Diane Blair-Sherlock
2026-05-27HouseAdded Alternate Co-Sponsor Rep. Martha Deuter
2026-05-27HouseAdded Alternate Co-Sponsor Rep. Nicolle Grasse
2026-05-27HouseThird Reading - Short Debate - Passed 106-000-000
2026-05-27HousePlaced on Calendar Order of 3rd Reading - Short Debate
2026-05-27HouseHouse Floor Amendment No. 1 Adopted by Voice Vote
2026-05-22HouseThird Reading/Final Action Deadline Extended-9(b) May 31, 2026
2026-05-20HouseHouse Floor Amendment No. 1 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000
2026-05-19HouseHeld on Calendar Order of Second Reading - Short Debate
2026-05-19HouseSecond Reading - Short Debate
2026-05-19HouseHouse Floor Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
2026-05-19SenateAdded as Co-Sponsor Sen. Chris Balkema
2026-05-15HouseHouse Floor Amendment No. 1 Referred to Rules Committee
2026-05-15HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Kelly M. Cassidy
2026-05-14HousePlaced on Calendar 2nd Reading - Short Debate
2026-05-13HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
2026-05-07HouseCommittee Deadline Extended-Rule 9(b) May 15, 2026
2026-04-27HouseAssigned to Prescription Drug Affordability & Accessibility Committee
2026-04-17HouseReferred to Rules Committee
2026-04-17HouseFirst Reading
2026-04-17HouseChief House Sponsor Rep. Kelly M. Cassidy
2026-04-17HouseArrived in House
2026-04-16SenateThird Reading - Passed; 057-000-000
2026-04-16SenateAdded as Chief Co-Sponsor Sen. Jason Plummer
2026-04-14SenatePlaced on Calendar Order of 3rd Reading ** April 15, 2026
2026-03-13SenateSenate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
2026-03-11SenatePlaced on Calendar Order of 3rd Reading March 12, 2026
2026-03-11SenateSenate Floor Amendment No. 2 Adopted; McClure
2026-03-11SenateSecond Reading
2026-03-10SenateSenate Floor Amendment No. 2 Be Approved for Consideration Assignments
2026-03-05SenateSenate Floor Amendment No. 2 Referred to Assignments
2026-03-05SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Steve McClure
2026-03-05SenatePlaced on Calendar Order of 2nd Reading March 10, 2026
2026-03-05SenateDo Pass Licensed Activities; 008-000-000
2026-03-04SenateSenate Committee Amendment No. 1 Postponed - Licensed Activities
2026-02-24SenateSenate Committee Amendment No. 1 Assignments Refers to Licensed Activities
2026-02-20SenateSenate Committee Amendment No. 1 Referred to Assignments
2026-02-20SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Steve McClure
2026-02-10SenateAssigned to Licensed Activities
2026-02-02SenateReferred to Assignments
2026-02-02SenateFirst Reading
2026-02-02SenateFiled with Secretary by Sen. Steve McClure

Code Citations

ChapterArticleSectionCitation TypeStatute Text
2258519Amended CodeCitation Text
720570311.6Amended CodeCitation Text

Illinois State Sources

TypeSource
Summaryhttps://www.ilga.gov/Legislation/BillStatus?DocNum=3213&GAID=18&DocTypeID=SB&SessionID=114&GA=104
Texthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=207260&DocName=10400SB3213&DocNum=3213&DocTypeID=SB&LegID=165914&GAID=18&SessionID=114&SpecSess=&Session=
Texthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=207260&DocName=10400SB3213eng&DocNum=3213&DocTypeID=SB&LegID=165914&GAID=18&SessionID=114&SpecSess=&Session=
Texthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=207260&DocName=10400SB3213enr&DocNum=3213&DocTypeID=SB&LegID=165914&GAID=18&SessionID=114&SpecSess=&Session=
Amendmenthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=209246&DocName=10400SB3213sam001&DocNum=3213&DocTypeID=SB&LegID=165914&GAID=18&SessionID=114&SpecSess=&Session=
Amendmenthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=209601&DocName=10400SB3213sam002&DocNum=3213&DocTypeID=SB&LegID=165914&GAID=18&SessionID=114&SpecSess=&Session=
Amendmenthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=211068&DocName=10400SB3213ham001&DocNum=3213&DocTypeID=SB&LegID=165914&GAID=18&SessionID=114&SpecSess=&Session=

feedback